Prevalence of persistent SARS-CoV-2 in a large community surveillance study.

Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
21 Feb 2024
Historique:
received: 29 01 2023
accepted: 04 01 2024
medline: 22 2 2024
pubmed: 22 2 2024
entrez: 21 2 2024
Statut: aheadofprint

Résumé

Persistent SARS-CoV-2 infections may act as viral reservoirs that could seed future outbreaks

Identifiants

DOI: 10.1038/s41586-024-07029-4 PMID: 38383783
pubmed: 38383783
doi: 10.1038/s41586-024-07029-4
pii: 10.1038/s41586-024-07029-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Dennehy, J. J., Gupta, R. K., Hanage, W. P., Johnson, M. C. & Peacock, T. P. Where is the next SARS-CoV-2 variant of concern? Lancet 399, 1938–1939 (2022).
pubmed: 35598619 pmcid: 9119661 doi: 10.1016/S0140-6736(22)00743-7
Otto, S. P. et al. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Curr. Biol. 31, R918–R929 (2021).
pubmed: 34314723 pmcid: 8220957 doi: 10.1016/j.cub.2021.06.049
Gonzalez-Reiche, A. S. et al. Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants. Nat. Commun. 14, 3235 (2023).
Hill, V. et al. The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK. Virus Evol. 8, veac080 (2022).
pubmed: 36533153 pmcid: 9752794 doi: 10.1093/ve/veac080
Ghafari, M., Liu, Q., Dhillon, A., Katzourakis, A. & Weissman, D. B. Investigating the evolutionary origins of the first three SARS-CoV-2 variants of concern. Front. Virol. https://doi.org/10.3389/fviro.2022.942555 (2022).
Choi, B. et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N. Engl. J. Med. 383, 2291–2293 (2020).
pubmed: 33176080 doi: 10.1056/NEJMc2031364
Kemp, S. A. et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature 592, 277–282 (2021).
pubmed: 33545711 pmcid: 7610568 doi: 10.1038/s41586-021-03291-y
Chaguza, C. et al. Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection. Cell Rep. Med. 4, 100943 (2023).
Swank, Z. et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciac722 (2023).
Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133–146 (2023).
pubmed: 36639608 pmcid: 9839201 doi: 10.1038/s41579-022-00846-2
Starr, T. N. et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182, 1295–1310.e20 (2020).
pubmed: 32841599 pmcid: 7418704 doi: 10.1016/j.cell.2020.08.012
McCarthy, K. R. et al. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science 371, 1139–1142 (2021).
pubmed: 33536258 pmcid: 7971772 doi: 10.1126/science.abf6950
Harari, S. et al. Drivers of adaptive evolution during chronic SARS-CoV-2 infections. Nat. Med. 28, 1501–1508 (2022).
pubmed: 35725921 pmcid: 9307477 doi: 10.1038/s41591-022-01882-4
Wilkinson, S. A. J. et al. Recurrent SARS-CoV-2 mutations in immunodeficient patients. Virus Evol. 8, veac050 (2022).
pubmed: 35996593 pmcid: 9384748 doi: 10.1093/ve/veac050
Rambaut, A. et al. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virological https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 (2020).
Avanzato, V. A. et al. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell 183, 1901–1912.e9 (2020).
pubmed: 33248470 pmcid: 7640888 doi: 10.1016/j.cell.2020.10.049
Cele, S. et al. SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape. Cell Host Microbe 30, 154–162.e5 (2022).
pubmed: 35120605 pmcid: 8758318 doi: 10.1016/j.chom.2022.01.005
Nussenblatt, V. et al. Yearlong COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with B-cell depletion. J. Infect. Dis. 225, 1118–1123 (2022).
pubmed: 34940844 doi: 10.1093/infdis/jiab622
Lythgoe, K. A. et al. SARS-CoV-2 within-host diversity and transmission. Science 372, eabg0821 (2021).
pubmed: 33688063 pmcid: 8128293 doi: 10.1126/science.abg0821
Braun, K. M. et al. Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks. PLoS Pathog. 17, e1009849 (2021).
pubmed: 34424945 pmcid: 8412271 doi: 10.1371/journal.ppat.1009849
Pouwels, K. B. et al. Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey. Lancet Public Health 6, e30–e38 (2021).
pubmed: 33308423 doi: 10.1016/S2468-2667(20)30282-6
Lythgoe, K. et al. Lineage replacement and evolution captured by 3 years of the United Kingdom Coronavirus (COVID-19) Infection Survey. Proc. R. Soc. B. 290, 20231284 (2023).
Kissler, S. M. et al. Viral dynamics of SARS-CoV-2 variants in vaccinated and unvaccinated persons. N. Engl. J. Med. 385, 2489–2491 (2021).
pubmed: 34941024 doi: 10.1056/NEJMc2102507
Jones, T. C. et al. Estimating infectiousness throughout SARS-CoV-2 infection course. Science 373, eabi5273 (2021).
pubmed: 34035154 pmcid: 9267347 doi: 10.1126/science.abi5273
Hodcroft, E. B. CoVariants: SARS-CoV-2 mutations and variants of interest. CoVariants https://covariants.org/ (2021).
Cox, M. et al. SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies. Nat. Rev. Microbiol. 21, 112–124 (2023).
pubmed: 36307535 doi: 10.1038/s41579-022-00809-7
Lin, J.-W. et al. Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response. Cell Host Microbe 29, 489–502.e8 (2021).
pubmed: 33548198 pmcid: 7846228 doi: 10.1016/j.chom.2021.01.015
Pereira, F. Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene. Infect. Genet. Evol. 85, 104525 (2020).
pubmed: 32890763 pmcid: 7467077 doi: 10.1016/j.meegid.2020.104525
Bloom, J. D. & Neher, R. A. Fitness effects of mutations to SARS-CoV-2 proteins. Virus Evol. 9, vead055 (2023).
Sanderson, T. et al. A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes. Nature 623, 594–600 (2023).
Gallichotte, E. N. et al. Early adoption of longitudinal surveillance for SARS-CoV-2 among staff in long-term care facilities: prevalence, virologic and sequence analysis. Microbiol. Spectr. 9, e0100321 (2021).
pubmed: 34756092 doi: 10.1128/Spectrum.01003-21
Hakki, S. et al. Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study. Lancet Respir. Med. 10, 1061–1073 (2022).
pubmed: 35988572 pmcid: 9388060 doi: 10.1016/S2213-2600(22)00226-0
Viloria Winnett, A. et al. Extreme differences in SARS-CoV-2 viral loads among respiratory specimen types during presumed pre-infectious and infectious periods. PNAS Nexus 2, gad033 (2023).
doi: 10.1093/pnasnexus/pgad033
Tom, M. R. & Mina, M. J. To interpret the SARS-CoV-2 test, consider the cycle threshold value. Clin. Infect. Dis. 71, 2252–2254 (2020).
pubmed: 32435816 doi: 10.1093/cid/ciaa619
Hay, J. A. et al. Estimating epidemiologic dynamics from cross-sectional viral load distributions. Science 373, eabh0635 (2021).
pubmed: 34083451 pmcid: 8527857 doi: 10.1126/science.abh0635
Fryer, H. R. et al. Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias. PLoS Pathog. 19, e1011461 (2023).
pubmed: 37578971 pmcid: 10449197 doi: 10.1371/journal.ppat.1011461
Owusu, D. et al. Persistent SARS-CoV-2 RNA shedding without evidence of infectiousness: a cohort study of individuals with COVID-19. J. Infect. Dis. 224, 1362–1371 (2021).
pubmed: 33649773 doi: 10.1093/infdis/jiab107
Munker, D. et al. Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients. Eur. Respir. J. 58, 2002724 (2021).
pubmed: 33602859 pmcid: 7898160 doi: 10.1183/13993003.02724-2020
Karthikeyan, S. et al. Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmission. Nature 609, 101–108 (2022).
pubmed: 35798029 pmcid: 9433318 doi: 10.1038/s41586-022-05049-6
Shafer, M. M. et al. Human origin ascertained for SARS-CoV-2 Omicron-like spike sequences detected in wastewater: a targeted surveillance study of a cryptic lineage in an urban sewershed. Preprint at medRxiv https://www.medrxiv.org/content/10.1101/2022.10.28.22281553v5 (2023).
Hay, J. A. et al. Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: a retrospective cohort study. eLife 11, e81849 (2022).
pubmed: 36383192 pmcid: 9711520 doi: 10.7554/eLife.81849
Ma, M.-J. et al. Persistent SARS-CoV-2 infection in asymptomatic young adults. Signal Transduct. Target. Ther. 7, 77 (2022).
pubmed: 35264553 pmcid: 8905556 doi: 10.1038/s41392-022-00931-1
Pulliam, J. R. C. et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science 376, eabn4947 (2022).
pubmed: 35289632 doi: 10.1126/science.abn4947
COVID-19 Forecasting Team. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. Lancet 401, 833–842 (2023).
doi: 10.1016/S0140-6736(22)02465-5
Marx, V. Scientists set out to connect the dots on long COVID. Nat. Methods 18, 449–453 (2021).
pubmed: 33911230 pmcid: 8081406 doi: 10.1038/s41592-021-01145-z
Schultheiß, C. et al. Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. J. Med. Virol. 95, e28364 (2023).
pubmed: 36458566 doi: 10.1002/jmv.28364
Stein, S. R. et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612, 758–763 (2022).
pubmed: 36517603 pmcid: 9749650 doi: 10.1038/s41586-022-05542-y
Maffia-Bizzozero, S. et al. Viable SARS-CoV-2 Omicron sub-variants isolated from autopsy tissues. Front. Microbiol. 14, 1192832 (2023).
pubmed: 37283920 pmcid: 10240073 doi: 10.3389/fmicb.2023.1192832
Yang, C., Zhao, H., Espín, E. & Tebbutt, S. J. Association of SARS-CoV-2 infection and persistence with long COVID. Lancet Respir. Med. 11, 504–506 (2023).
pubmed: 37178694 pmcid: 10171832 doi: 10.1016/S2213-2600(23)00142-X
Vihta, K. D. et al. Symptoms and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positivity in the general population in the United Kingdom. Clin. Infect. Dis. 75, e329–e337 (2022).
pubmed: 34748629 doi: 10.1093/cid/ciab945
COG-UK. COG-UK publication. Protocols.io https://www.protocols.io/workspaces/coguk/publications (2020).
Connor Lab. ncov2019-artic-nf. GitHub https://github.com/connor-lab/ncov2019-artic-nf (2020).
Bonsall, D. et al. A comprehensive genomics solution for HIV surveillance and clinical monitoring in low-income settings. J. Clin. Microbiol. 58, e00382-20 (2020).
pubmed: 32669382 pmcid: 7512176 doi: 10.1128/JCM.00382-20
Wymant, C. et al. Easy and accurate reconstruction of whole HIV genomes from short-read sequence data with shiver. Virus Evol. 4, vey007 (2018).
pubmed: 29876136 pmcid: 5961307 doi: 10.1093/ve/vey007
Cevik, M. et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe 2, e13–e22 (2021).
pubmed: 33521734 doi: 10.1016/S2666-5247(20)30172-5
Minh, B. Q. et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol. Biol. Evol. 37, 1530–1534 (2020).
pubmed: 32011700 pmcid: 7182206 doi: 10.1093/molbev/msaa015
Hoang, D. T., Chernomor, O., von Haeseler, A., Minh, B. Q. & Vinh, L. S. UFBoot2: improving the ultrafast bootstrap approximation. Mol. Biol. Evol. 35, 518–522 (2018).
pubmed: 29077904 doi: 10.1093/molbev/msx281
Rambaut, A., Lam, T. T., Max Carvalho, L. & Pybus, O. G. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen). Virus Evol. 2, vew007 (2016).
pubmed: 27774300 pmcid: 4989882 doi: 10.1093/ve/vew007
Yu, G., Smith, D. K. & Tsan-Yuk, Z. H. L. ggtree: An R package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol. Evol. 8, 28–36 (2017).
doi: 10.1111/2041-210X.12628
Shapiro, S. S. & Wilk, M. B. An analysis of variance test for normality (complete samples). Biometrika 52, 591–611 (1965).
doi: 10.1093/biomet/52.3-4.591
Walker, A. J. et al. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br. J. Gen. Pract. 71, e806–e814 (2021).
pubmed: 34340970 pmcid: 8340730 doi: 10.3399/BJGP.2021.0301
COVID-19 Genomics UK (COG-UK) Consortium. An integrated national scale SARS-CoV-2 genomic surveillance network. Lancet Microbe 1, e99–e100 (2020).
doi: 10.1016/S2666-5247(20)30054-9

Auteurs

Mahan Ghafari (M)

Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. mahan.ghafari@ndm.ox.ac.uk.
Department of Biology, University of Oxford, Oxford, UK. mahan.ghafari@ndm.ox.ac.uk.
Pandemic Science Institute, University of Oxford, Oxford, UK. mahan.ghafari@ndm.ox.ac.uk.
ORCID: 0000-0002-4123-3287

Matthew Hall (M)

Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Pandemic Science Institute, University of Oxford, Oxford, UK.
ORCID: 0000-0002-2671-3864

Tanya Golubchik (T)

Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Sydney Infectious Diseases Institute (Sydney ID), School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
ORCID: 0000-0003-2765-9828

Daniel Ayoubkhani (D)

Office for National Statistics, Newport, UK.
Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester, UK.

Thomas House (T)

Department of Mathematics, University of Manchester, Manchester, UK.
ORCID: 0000-0001-5835-8062

George MacIntyre-Cockett (G)

Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.

Helen R Fryer (HR)

Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Laura Thomson (L)

Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Pandemic Science Institute, University of Oxford, Oxford, UK.

Anel Nurtay (A)

Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Steven A Kemp (SA)

Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Department of Biology, University of Oxford, Oxford, UK.
Pandemic Science Institute, University of Oxford, Oxford, UK.
ORCID: 0000-0001-7077-6793

Luca Ferretti (L)

Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Pandemic Science Institute, University of Oxford, Oxford, UK.
ORCID: 0000-0001-7578-7301

David Buck (D)

Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.

Angie Green (A)

Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.

Amy Trebes (A)

Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
ORCID: 0000-0002-3715-9109

Paolo Piazza (P)

Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.

Lorne J Lonie (LJ)

Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.

Ruth Studley (R)

Office for National Statistics, Newport, UK.

Emma Rourke (E)

Office for National Statistics, Newport, UK.

Darren L Smith (DL)

The Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.

Matthew Bashton (M)

The Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
ORCID: 0000-0002-6847-1525

Andrew Nelson (A)

Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.

Matthew Crown (M)

The Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
ORCID: 0000-0002-5091-6282

Clare McCann (C)

Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.

Gregory R Young (GR)

The Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
ORCID: 0000-0001-5342-1421

Rui Andre Nunes Dos Santos (RAND)

Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
ORCID: 0000-0002-2070-5126

Zack Richards (Z)

Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
ORCID: 0000-0002-5392-6558

Mohammad Adnan Tariq (MA)

Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.

Roberto Cahuantzi (R)

Office for National Statistics, Newport, UK.

Jeff Barrett (J)

Wellcome Sanger Institute, Cambridge, UK.
ORCID: 0000-0002-1152-370X

Christophe Fraser (C)

Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Pandemic Science Institute, University of Oxford, Oxford, UK.
Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
Wellcome Sanger Institute, Cambridge, UK.
ORCID: 0000-0003-2399-9657

David Bonsall (D)

Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Pandemic Science Institute, University of Oxford, Oxford, UK.
Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headington, Oxford, UK.

Ann Sarah Walker (AS)

Nuffield Department of Medicine, University of Oxford, Oxford, UK.
The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK.
The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
MRC Clinical Trials Unit at UCL, UCL, London, UK.

Katrina Lythgoe (K)

Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. katrina.lythgoe@biology.ox.ac.uk.
Department of Biology, University of Oxford, Oxford, UK. katrina.lythgoe@biology.ox.ac.uk.
Pandemic Science Institute, University of Oxford, Oxford, UK. katrina.lythgoe@biology.ox.ac.uk.
ORCID: 0000-0002-7089-7680

Classifications MeSH